J. Langhorst and J. Boone
Drugs of Today 2012, 48(2): 149-161
Potential applications for lactoferrin measurements include a biomarker for mucosal healing and a noninvasive method for following medical and surgical treatment in patients with IBD.
TECHLAB® PUBLICATIONS
J. Boone, M. Goodykoontz, S. Rhodes, K. Price, J. Smith, K. Gearhart, R. Carman, T. Kerkering, T. Wilkins, D. Lyerly
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31(7): 1551-1559
Significantly different prevalence rates in clinically indicated specimens were observed based on patient population and age, the presence of nontoxigenic isolates in all stratified populations, and fluoroquinolone resistance in ARL 027 and non-027 ribotypes.
R. Carman, K. Wickham, L. Chen, A. Lawrence, J. Boone, T. Wilkins, T. Kerkering, D. Lyerly
Journal of Clinical Microbiology 2012, 52(5): 1425-1426
All isolates and ribotypes expressed GDH at levels 500-fold or more above the minimum detection levels of TECHLAB®‘s commercial GDH assays.